SCA
CL icon

Salient Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Salient Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-111,952
Closed -$8.3M – 82
2017
Q2 		$8.3M Buy
111,952
+13,466
+14% +$1,000K 0.16% 54
2017
Q1 		$7.21M Buy
98,486
+14,697
+18% +$1.03M 0.13% 55
2016
Q4 		$5.48M Buy
83,789
+2,963
+4% +$203K 0.1% 56
2016
Q3 		$5.99M Sell
80,826
-6,501
-7% -$481K 0.12% 60
2016
Q2 		$6.39M Buy
87,327
+6,781
+8% +$483K 0.14% 60
2016
Q1 		$5.69M Sell
80,546
-6,190
-7% -$412K 0.16% 62
2015
Q4 		$5.78M Sell
86,736
-13,605
-14% -$905K 0.15% 67
2015
Q3 		$6.37M Buy
100,341
+3,720
+4% +$243K 0.15% 65
2015
Q2 		$6.32M Buy
96,621
+2,850
+3% +$193K 0.12% 77
2015
Q1 		$6.5M Buy
93,771
+10,910
+13% +$754K 0.12% 69
2014
Q4 		$5.73M Buy
82,861
+15,730
+23% +$1.06M 0.11% 71
2014
Q3 		$4.38M Buy
67,131
+14,978
+29% +$988K 0.08% 88
2014
Q2 		$3.56M Buy
52,153
+8,656
+20% +$580K 0.08% 84
2014
Q1 		$2.82M Buy
43,497
+26,932
+163% +$1.7M 0.08% 84
2013
Q4 		$1.08M Buy
+16,565
New +$1.06M 0.03% 118

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Salient Capital Advisors's CL Position: Q3 2017 in Review

Salient Capital Advisors sold out of Colgate-Palmolive (CL) in Q3 2017, closing a stake of 111,952 shares — an estimated $8.3M sold.

Salient Capital Advisors first reported a position in CL in Q4 2013 and held it in 15 quarters. The position peaked at $8.3M in Q2 2017. 1,357 funds tracked by Wall St. Rank hold CL as of Q3 2017.

  • Salient Capital Advisors reported no remaining Colgate-Palmolive position as of Q3 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 111,952 Colgate-Palmolive shares in Q3 2017, an estimated $8.3M.
  • Salient Capital Advisors first reported a position in Colgate-Palmolive in Q4 2013 and held it in 15 quarters.
  • Salient Capital Advisors's Colgate-Palmolive position peaked at $8.3M in Q2 2017.
  • 1,357 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.